Read the full article in ADA Meeting News: To view or add a comment, sign in More Relevant Posts At #ADASciSessions, Klara Klein, MD, PhD, and other experts will discuss emerging trial data examining the potential benefits of GLP-1/GIP receptor agonists for people living with type 1 diabetes
Potential Benefits (What We Can Hope For) Slowing or delaying onset of dementia , especially in people with risk factors: T2DM, obesity, metabolic syndrome, hypertension
Within the time frame of January 2023 and January 2024, three sessions were held that included four gastroenterology specialists and three endocrinology specialists, for the purpose of reviewing and discussing the scientific evidence collected
Unlike other options, Foundayo is designed for convenience
No clutter
thus, liraglutide-induced autophagy in hippocampal neurons is induced by the AMPK/mTOR pathway [54]